iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA's Update GLP-1 RA prescription trends: January

Potential benefits of Tirzepatide: Greater weight loss than Semaglutide in many studies Improved glycemic control Reduced appetite Improved metabolic markers Comparing These Five Therapies | Therapy | Primary Target | Main Goal | |---|---|---| | AOD-9604 | Fat metabolism | Fat mobilization | | MOTS-c | Mitochondria / AMPK | Metabolic optimization | | Tesamorelin | GHRH receptor | Reduce visceral fat | | Semaglutide | GLP-1 receptor | Appetite reduction | | Tirzepatide | GLP-1 + GIP receptors | Maximum weight loss | Which Therapy Produces the Most Weight Loss

13 While concerns about the mental health risks of GLP-1 receptor agonists have been raised, evidence is largely inconclusive

[12] [13] However, portion control remains important when following a calorie-controlled diet alongside Wegovy treatment

Os efeitos colaterais mais comuns esto relacionados ao trato gastrointestinal, especialmente no incio do tratamento